The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 437-454

Bentham Science Publishers

Access to resources Recommend Favorite

Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats

By Hotta H.   Ito H.   Kagitani F.   Sato A.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 49-52

Elsevier

Access to resources Recommend Favorite

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

By Silver P.J.   Pagani E.D.   Dundore R.L.   de Garavilla L.   Bode D.C.   Bacon E.R.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 263-268

Elsevier

Access to resources Recommend Favorite

Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells

By Ikeda U.   Ikeda M.   Kano S.   Kanbe T.   Shimada K.  

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite

The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function

By Miller A.H.   Vogt G.J.   Pearce B.D.  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 939-948

Elsevier

Access to resources Recommend Favorite